Glisoxepide: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{chembox | verifiedrevid = 443837353 |ImageFile=Glisoxepide.png |ImageSize=200px |ImageFile1=Glisoxepide ball-and-stick.png |ImageSize1=200px |IUPACName= |OtherNames= |Sectio...") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{ | {{chembox2 | ||
| verifiedrevid = 443837353 | | verifiedrevid = 443837353 | ||
|ImageFile= | |ImageFile=Glisoxepide1.png | ||
|ImageSize=200px | |ImageSize=200px | ||
|ImageFile1= | |ImageFile1=Glisoxepide2.png | ||
|ImageSize1=200px | |ImageSize1=200px | ||
|IUPACName= | |IUPACName= | ||
Revision as of 19:20, 7 April 2015
Template:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox E numberTemplate:Chembox Supplement
| Template:Chembox header2 | Glisoxepide | |
|---|---|
| Identifiers | |
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
| KEGG | |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C20H27N5O5S | |
| Molar mass | 449.52388 g/mol |
| Template:Chembox header2 | Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
Glisoxepide (INN) is an anti-diabetic drug from the group of sulfonylureas.[1]
References
- ↑ Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). "Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects". Diabetologia. 7 (6): 449–54. doi:10.1007/bf01212061. PMID 5004178.